Theriva Biologics Inc (TOVX)

[BooDog]

TOVX (aka SYN) .712 Still on my list for playing the technical side.

TOVX pincher

[Frog77]

sign Name symbol change Tovx 
  
 
$SYN $TOVX Synthetic completes transformation with new name and cancer-killing virus focus - https://t.co/JKYaOcSNlX
— bio | tech | pharma stock scope (@MarcJacksonLA) October 12, 2022



  
 “new name & cancer killing virus focus” 
  
  https://www.ft.com/ Finacialtimes nov 1 2022 
  “ investors return to hunt for biotech bargains’  
 “...people dont want to die, it’s pretty basic.”   
  
 https://therivabio.com/#about 

[BooDog]

Wow, already about to the $. That didn't take long at all.

[ALERTS100%to10000%GAIN]

Synthetic Biologics to Participate in the BTIG Biotechnology Conference 2022
08/04/2022 | 04:07pm EDT
share with twitter
share with LinkedIn
share with facebook
ROCKVILLE, Md., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced that Company’s management will participate in one-on-one investor meetings at the BTIG Biotechnology Conference 2022, to be held virtually and in New York City from August 8-9, 2022.

BTIG hosted events are intended for prospective and existing BTIG clients only. To schedule a meeting with the Company, please contact your BTIG representative.

About Synthetic Biologics, Inc.

Synthetic Biologics, Inc. (NYSE American: SYN) is a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need. The Company recently consummated the acquisition of VCN Biosciences, S.L. (VCN), which is developing a new oncolytic adenovirus (OV) platform designed for intravenous (IV), intravitreal and antitumoral delivery to trigger tumor cell death, improve access of co-administered cancer therapies to the tumor, and promote a robust and sustained anti-tumor response by the patient’s immune system. The Company's lead candidates are: (1) VCN-01, an oncolytic adenovirus designed to replicate selectively and aggressively within tumor cells, and to degrade the tumor stroma barrier that serves as a significant physical and immunosuppressive barrier to cancer treatment; (2) SYN-004 (ribaxamase) which is designed to degrade certain commonly used IV beta-lactam antibiotics within the gastrointestinal (GI) tract to prevent (a) microbiome damage, (b) Clostridioides difficile infection (CDI), (c) overgrowth of pathogenic organisms, (d) the emergence of antimicrobial resistance (AMR), and (e) acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant (HCT) recipients, and (3) SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) produced under cGMP conditions and intended to treat both local GI and systemic diseases. For more information, please visit Synthetic Biologics' website at www.syntheticbiologics.com.

For further information, please contact:

Investor Relations:

Chris Calabrese

LifeSci Advisors, LLC

[e-mail]

917-680-5608




Primary Logo
Source: Synthetic Biologics, Inc.
2022 GlobeNewswire, Inc., source Press Releases

share with twitter
share with LinkedIn
share with facebook

[otterman]

$3MM offering done just to keep the lights on.

[Tom turtles]

Was holding pre split though.....got robbed already there ...

[Tom turtles]

Sorry....$2.37.....

[Tom turtles]

OS is so low.....dammmm....I sold 5000 at $1.90....thought that was good ..till it ran to $1.37????

[66]

Yuuup!! Picked some 1.40s today, glad I did!! And already took a small profit ah .. now gonna ride the wave. How high can SYN goooo?..

[Tom turtles]

SYN ? $1.84 after hours. Up 28%

[66]

Same imo

[Tom turtles]

If I would've shorted every stock in my arsenal....I'd be a multi millionaire in a year

[Tom turtles]

No need huh ? Well.....now they have 15 M O/S.....I guess we can hope for a short squeeze before they start bloating this pig out again. Still can't believe they did a rs with only 150M 0/S.....guess they need a buck....friggen assholes

[Tom turtles]

So I need $2.40.....just to get back to .24 cents pre split ? What a fucking scam.

[Tom turtles]

R/S ....of course ! Mother tappers

[66]

More undervalued shares available here imo $$$

[BooDog]

News: On July 8, 2022, Synthetic Biologics, Inc. (the “Company”) was notified of the clearance of the safety evaluation period by the first patient that had been dosed in the investigator sponsored Phase 1 clinical trial evaluating VCN-01 (NCT05057715), an intravenous oncolytic adenovirus, in combination with mesothelin-directed lentiviral transduced human chimeric antigen receptor modified T cells (huCART-meso) for patients with pancreatic and serious epithelial ovarian cancers. VCN-01 was developed by Synthetic Biologics’ wholly-owned subsidiary VCN Biosciences, SL.



The Phase 1, open-label, non-randomized trial, which is the first clinical trial of VCN-01 being conducted in the US, is designed to evaluate the safety and feasibility of intravenously administered VCN-01 in combination with mesothelin-directed lentiviral transduced huCART-meso cells in a 3+3 dose design for patients with pancreatic or serous epithelial ovarian cancers. VCN-01 will be administered at a single dose of 3.3x1012 vp (cohort 1) or 1 x 1013 vp (cohort 2) followed by a single dose of 5x107 huCART-meso cells on Day 14. The trial may also evaluate the safety of a different sequence of administration for these two investigational products at the same dose levels used in cohort 1.

https://ih.advfn.com/p.php?pid=nmona&article=88593706

[Tom turtles]

Hopefully.....this is over due.

[66]

SYN is inching up slowly $$$$ loaded up and ready to run

[Tom turtles]

Volume picking up....loading these low-ball twenties

[Little Run]

Amex, no need.

[Tom turtles]

Any history of RS here ?

[Tom turtles]

Big move coming. Well overdue

[Tom turtles]

I'm trying.....

[BooDog]

Anyone have a nitro injector to get this puppy moving!!??

[JusticeWillWin]

Chart=====>Unfilled gap between $0.988 and $0.9902

[66]

Looking at Form D, filed yesterday, it looks like they did imo SYN

[TheFinalCD]

did they close the recent offering?

[66]

$SYN is looking primed and ready imo

[TheFinalCD]

just never saw that b4

[Dark Alpha]

Smart Money - Do you mean they have zero or little revenue but declined to disclose it?

[TheFinalCD]

x Decline to Disclose

https://ih.advfn.com/stock-market/AMEX/synthetic-biologics-SYN/stock-news/87610710/small-company-offering-and-sale-of-securities-with

[splintered sunlight]

Now we're talking.

[Tom turtles]

We're on our way past a buck in the coming months...

[splintered sunlight]

Yes we are but I still need a lot more...

[Little Run]

OK Splint, we’re gaining on it...nice little pump in progress.

[Tom turtles]

Earnings....they missed by a penny...but revenues better than expected.

[Bmaintz]

Wow, what is the good news for the upswing??_____

[JusticeWillWin]

$SYN before HUGE BREAKOUT? Look at these similarities!

And there's an UNFILLED GAP between $0.988 and $0.9902

[Brickwall10]

Oh ok

[splintered sunlight]

It's a start - I have a long way to go....

[Little Run]

Here we go!!!

[Tom turtles]

SYN to Win......

[wilabee]

I think we presented this morning at the 2022 BIO CEO & Investor Conference. It must have went well. That would explain the pop.

[wilabee]

Wake up! This is not dead! We're up again today. Volume is still low but it's picking up. I added another 13,000 shares today. GL

[splintered sunlight]

A splinter of sunshine.....

[TheFinalCD]

better than pulm

$SYN

[Little Run]

A ray of hope today...

[splintered sunlight]

VERY DISAPPOINTED IN THIS ONE

[BooDog]

Be nice to see this puppy get its game on!!!! How bout some .27's!.